11:12 AM
May 11, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Chinese immuno-oncology play CStone raises $260M

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) raised on May 8 $260 million in a series B round led by new investor GIC Private. CStone said the round is the largest series B ever for a Chinese biopharma.

New investors in the round included Sequoia China, Yunfeng Capital, 6 Dimensions Capital, CITIC PE,...

Read the full 239 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >